Debt-laden SP Group seeks $1.3 billion through realty IPO and energy asset sales
Mumbai: Shapoorji Pallonji (SP) Group, the Mumbai-headquartered real estate and infrastructure conglomerate run by billionaire Shapoor Mistry, is planning to raise $1.3 billion (about ₹11,500 crore) over the next two years by taking its real estate business public, and by selling some assets in its oil and gas businesses.
The move is part of a bigger plan to manage the group's rising debts. The money raised will be used to make interim payments to creditors of a recent $3.3 billion private credit loan that the group took last week, according to the deal's term sheet. The $3.3-billion deal in turn was taken to refinance and repay some other, older loans.
SP Group has total outstanding debt of ₹55,000- ₹60,000 crore as of 31 March 2024, according to news reports. Nearly ₹32,000 crore has reportedly been raised from global private credit funds and wealthy high net-worth individuals over the past three years in two tranches via non-convertible debentures.
To raise fresh funds of $1.3 billion, the group is looking to list its real estate business, Shapoorji Pallonji Real Estate, which is valued at around $5 billion, according to lenders who spoke with Mint. The IPO could see the company selling shares worth ₹4,000-5,000 crore, per a Moneycontrol report in December last year. It would also be the second IPO from the SP Group stable since October 2024, when construction firm Afcons Infrastructure was listed to raise ₹5,430 crore.
In parallel, the group's oil and gas company, SP Energy, also plans to sell two FPSOs (floating production storage and offloading), which are estimated to be valued at around $800 million, according to the lenders cited above. FPSO units are floating offshore facilities used in the oil and gas industry to process and store hydrocarbons.
Emails to SP group remained unanswered till press time.
'SP group has been very focused in doing what they have committed to their bond holders," one of the lenders cited earlier said on condition of anonymity, adding that it is reflected in the fact that they have been consistently selling assets.
'So if you look at the Afcon sale or prior to that when they had to pay back the banks after the restructuring, which happened during covid, they sold a bunch of assets," this person added. 'So they have been selling all off their assets to make sure that their lender community gets paid."
Piling on debt
Earlier this week, SP group signed the country's largest private credit deal with a consortium of lenders to raise $3.3 billion through a three-year zero-coupon bond at an annual yield of 19.75%. The proceeds of this transaction will be used to refinance existing debt taken about three years ago by the group's main investment vehicle Sterling Investment Corp.
The holding companies–Sterling Investment and Cyrus Investment–had borrowed ₹26,000 crore as of March 2024 against the SP group's 9.2% stake in Tata Sons (holding company of the Tata Group), and pledged shares of Shapoorji Pallonji Real Estate and SP Energy.
Ares, Farallon, Cerberus Capital Management and Davidson Kempner are likely to be the largest subscribers of this bond, according to lenders cited above. Others such as PIMCO, BlackRock and Edelweiss Alternatives have also subscribed to smaller amounts, according to these lenders.
The proceeds from this bond will also be used to refinance a ₹14,300 crore debt taken by group company Goswami Infratech Private Limited (GIPL), of which it had repaid ₹7,500 crore through funds raised from the Afcons listing and monetization of port assets such as Gopalpur Port and Dharamtar Port.
GIPL is an equally held joint venture between SC Finance and Investments Private Limited and SP Finance Private Limited, which are in turn promoted by the Mistry family.
The $3.3-billion fund raising from private credit funds came after its request for a ₹20,000 crore loan from Power Finance Corporation was turned down. PFC's board had raised concerns regarding the NBFC's ability to underwrite the loan to SP group, which had large exposure to real estate construction and infrastructure.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
2 hours ago
- Economic Times
KKR-backed IVI to buy ART Fertility Clinics for $450 million
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel KKR-backed IVI RMA Global, a US-based leader in infertility treatment, is set to acquire ART Fertility Clinics for $400-450 million, according to people familiar with the matter. The acquisition marks a significant step in IVI RMA's global expansion, adding India to its presence in over 15 countries and more than 190 clinical offices across the US, Europe and Latin parties are in the final stages of documentation for a shareholders' agreement and are hoping to wrap up the transaction by June with private hospitals, the IVF industry in India too is witnessing consolidation as several private equity funds have been aggressive with acquisitions. In 2023, Swedish fund EQT Partners acquired a significant majority stake in Indira IVF, the largest provider of fertility services in India and top five globally in terms of annual IVF cycles, at a $1.1 billion ('9,000 crore) Fertility Clinics began in 2015 as IVI Middle East, an international arm of IVI RMA Global. In 2020, IVI RMA divested the business to Gulf Capital, which rebranded it as ART Fertility Clinics. Since then, the brand has rapidly grown, expanding across West Asia and clinics in Abu Dhabi, Dubai and Al Ain in the UAE as well as 11 centres across India, ART Fertility has established itself as a high-performance network in reproductive medicine. The Indian expansion began in 2021, backed by a $30 million investment from Gulf Fertility operates in big Indian cities including Mumbai, Noida, Ahmedabad, Chennai, Hyderabad, Gurgaon and by Suresh Soni, former co-founder and CEO of Nova IVF Fertility, ART Fertility reports a pregnancy success rate of 70% and has recorded over 5,000 successful pregnancies in under nine to sources, ART Fertility posted revenue of $100-120 million in FY25, with an estimated Ebitda of $35 million."For an Indian healthcare player, a $25-35 million ebitda which is borderline ebitda positive coming from the Middle East would add no value," said a fund manager at a Mumbai-based private equity firm that operates a pan-India IVF chain. "However, IVI being a US player where multiples are low, adding a Middle East business works well."IVI RMA trumped a rival bid by Temasek-backed Cloudnine Hospitals.A KKR spokesperson declined to comment. IVI RMA and ART Fertility did not respond to is the advisor in the is rapidly emerging as one of the world's fastest-growing markets for Assisted Reproductive Technology (ART). However, the sector has scope for expansion at 210 IVF cycles per million people, compared with 1,200 in the US and over 2,000 in affects approximately 15% of Indian couples, a figure expected to rise due to lifestyle factors such as poor diet, stress, late marriages, and to EY, India's IVF market is expected to grow from $793 million in 2020 to $1.45 billion by 2027, at a projected CAGR of 15-20%.India sees around 300,000 IVF cycles annually, with projections suggesting this could grow to 500,000-600,000 cycles by 2030. About 30% of the market is controlled by 10-15 organised players, while the remaining is fragmented among smaller, unorganised clinics. Key players in India's fertility sector include Indira IVF, Nova IVF, Oasis IVF, Bloom Fertility Centre, Bengaluru-based Milann, Morpheus IVF, Ridge IVF, Akanksha IVF and Bourn Hall IVF, the second largest player in India, is owned by Asia Healthcare Holdings (AHH), the single specialty hospitals platform backed by GIC and homegrown PE fund Kedaara Capital owns a minority stake in Oasis Fertility, while Brussels-based fund Verlinvest owns a controlling stake in Ferty9 F, a premier chain of fertility clinics in the AP/Telangana region.
Time of India
2 hours ago
- Time of India
KKR-backed IVI to buy ART Fertility Clinics for $450 million
KKR-backed IVI RMA Global, a US-based leader in infertility treatment, is set to acquire ART Fertility Clinics for $400-450 million, according to people familiar with the matter. The acquisition marks a significant step in IVI RMA's global expansion, adding India to its presence in over 15 countries and more than 190 clinical offices across the US, Europe and Latin America. Both parties are in the final stages of documentation for a shareholders' agreement and are hoping to wrap up the transaction by June end. As with private hospitals, the IVF industry in India too is witnessing consolidation as several private equity funds have been aggressive with acquisitions. In 2023, Swedish fund EQT Partners acquired a significant majority stake in Indira IVF, the largest provider of fertility services in India and top five globally in terms of annual IVF cycles, at a $1.1 billion ('9,000 crore) valuation. ART Fertility Clinics began in 2015 as IVI Middle East, an international arm of IVI RMA Global. In 2020, IVI RMA divested the business to Gulf Capital, which rebranded it as ART Fertility Clinics. Since then, the brand has rapidly grown, expanding across West Asia and India. Live Events With clinics in Abu Dhabi, Dubai and Al Ain in the UAE as well as 11 centres across India, ART Fertility has established itself as a high-performance network in reproductive medicine. The Indian expansion began in 2021, backed by a $30 million investment from Gulf Capital. ART Fertility operates in big Indian cities including Mumbai, Noida, Ahmedabad, Chennai, Hyderabad, Gurgaon and Faridabad. Led by Suresh Soni, former co-founder and CEO of Nova IVF Fertility, ART Fertility reports a pregnancy success rate of 70% and has recorded over 5,000 successful pregnancies in under nine years. According to sources, ART Fertility posted revenue of $100-120 million in FY25, with an estimated Ebitda of $35 million. "For an Indian healthcare player, a $25-35 million ebitda which is borderline ebitda positive coming from the Middle East would add no value," said a fund manager at a Mumbai-based private equity firm that operates a pan-India IVF chain. "However, IVI being a US player where multiples are low, adding a Middle East business works well." IVI RMA trumped a rival bid by Temasek-backed Cloudnine Hospitals. A KKR spokesperson declined to comment. IVI RMA and ART Fertility did not respond to queries. Moelis is the advisor in the transaction. India is rapidly emerging as one of the world's fastest-growing markets for Assisted Reproductive Technology (ART). However, the sector has scope for expansion at 210 IVF cycles per million people, compared with 1,200 in the US and over 2,000 in Europe. Infertility affects approximately 15% of Indian couples, a figure expected to rise due to lifestyle factors such as poor diet, stress, late marriages, and pollution. According to EY, India's IVF market is expected to grow from $793 million in 2020 to $1.45 billion by 2027, at a projected CAGR of 15-20%. India sees around 300,000 IVF cycles annually, with projections suggesting this could grow to 500,000-600,000 cycles by 2030. About 30% of the market is controlled by 10-15 organised players, while the remaining is fragmented among smaller, unorganised clinics. Key players in India's fertility sector include Indira IVF, Nova IVF, Oasis IVF, Bloom Fertility Centre, Bengaluru-based Milann, Morpheus IVF, Ridge IVF, Akanksha IVF and Bourn Hall Clinic. Nova IVF, the second largest player in India, is owned by Asia Healthcare Holdings (AHH), the single specialty hospitals platform backed by GIC and TPG. Similarly, homegrown PE fund Kedaara Capital owns a minority stake in Oasis Fertility, while Brussels-based fund Verlinvest owns a controlling stake in Ferty9 F, a premier chain of fertility clinics in the AP/Telangana region.
Time of India
6 hours ago
- Time of India
Major 26 listed realty firms sell ₹1.62 lakh crore properties in FY25
NEW DELHI: India's 26 major listed real estate firms sold properties valuing Rs 1.62 lakh crore last fiscal, with Godrej Properties becoming largest player clocking pre-sales of nearly Rs 30,000 crore. DLF Ltd, the biggest real estate firm in terms of market capitalisation, is at the second position with record sale bookings of over Rs 21,000 crore during 2024-25, followed by Macrotech Developers (Lodha Group), Prestige Estates Projects and Signature Global . According to the data compiled from investors presentations and regulatory filings, the 26 major listed real estate companies reported a combined sales bookings or pre-sales of Rs 1,61,722 crore in the last fiscal year, a more than 20 per cent increase from 2023-24. Bulk of pre-sales (sales bookings) came from residential segment especially luxury homes, with small contribution from commercial properties. In terms of annual sales bookings, Godrej Properties emerged as the largest listed player during last fiscal with pre-sales of Rs 29,444 crore. Its pre-sales stood at Rs 22,527 crore during 2023-24. DLF's sales bookings rose to Rs 21,223 crore from Rs 14,778 crore driven by strong sales in its ultra luxury housing project The Dahlias in Gurugram. Mumbai-based Macrotech Developers Ltd reported sale bookings of Rs 17,630 crore in FY25 as against Rs 14,520 crore in the preceding year. Bengaluru-based Prestige Estates Projects clocked sale bookings of Rs 17,023 crore last fiscal as against Rs 21,040 crore in 2023-24. Delhi-NCR based Signature Global achieved sales bookings of Rs 10,290 crore as against Rs 7,270 crore. There were many real estate firms which clocked annual sales between Rs 5,000 crore and Rs 10,000 crore. Mumbai-based Aditya Birla Real Estate sold properties worth Rs 8,087 crore last fiscal, a sharp jump from Rs 3,985 crore in the preceding year. Bengaluru-based Brigade Enterprises reported a sales bookings of Rs 7,847 crore as against Rs 6,013 crore. Sobha Ltd's pre-sales fell to Rs 6,277 crore from Rs 6,644 crore. Delhi-NCR-based Max Estates sold properties worth Rs 5,321 crore last fiscal as against Rs 1,844 crore in the preceding year. Mumbai-based Oberoi Realty sold properties worth Rs 5,281 crore in FY25. Puravankara Ltd sales bookings declined to Rs 5,006 crore from Rs 5,914 crore. In below Rs 5,000 crore annual pre-sales category, Delhi-based TARC Ltd sold properties worth Rs 3,722 crore as against Rs 1,612 crore in FY24. Mumbai-based Keystone Realtors (Rustomjee) sale bookings grew to Rs 3,028 crore from Rs 2,266 crore. Mahindra Lifespace Developers' pre-sales rose to Rs 2,804 crore from Rs 2,328 crore. Pune based Kolte-Patil Developers Ltd sales fell marginally to Rs 2,791 crore from Rs 2,822 crore. Sales bookings of Sunteck Realty went up to Rs 2,531 crore from Rs 1,915 crore. Raymond Ltd sold properties worth Rs 2,310 crore last fiscal as against Rs 2,249 crore in the preceding year. Bengaluru-based Shriram Properties sales bookings fell to Rs 2,288 crore from Rs 2,362 crore. Embassy Developments clocked sales of Rs 2,031 crore last fiscal as against Rs 1,838 crore in 2023-24. There were many players that reported annual pre-sales below Rs 2,000 crore. Delhi-based Ashiana Housing Ltd reported sales bookings of Rs 1,936.75 crore during the last fiscal as against Rs 1,798.22 crore in the preceding year. Ahmedabad-based Arvind Smartspaces sold properties worth Rs 1,271 crore FY25 as against Rs 1,107 crore in the preceding year. Ajmera Realty & Infrastructure Ltd sales bookings grew to Rs 1,080 crore from Rs 1,017 crore. Arihant SuperstructuresLtd sales bookings stood at Rs 888.7 crore as against Rs 970.6 crore. Arkade Developers' sales bookings grew to Rs 773 crore from Rs 645 crore. Suraj Estate Developers sold properties worth Rs 501 crore in FY25 as against Rs 483 crore in the preceding year. Lucknow-based Eldeco Housing & Industries Ltd clocked pre-sales of Rs 337.5 crore last fiscal as against Rs 388.7 crore in the 2023-24 financial year. Sale bookings data of many listed players was not available on the stock exchanges. Market experts attributed the strong performance of listed players to a gradual shift in consumers preference towards branded and reputed players which have better track record of executing real estate projects. With lakhs of homebuyers still stuck in stalled housing projects, the prospective customers do not want to take risk on their investments.
